BACKGROUND AND PURPOSE: This study aimed to test the explanatory qualities of the Stroke-Thrombolytic Predictive Instrument (S-TPI) when applied to patients treated in routine practice. METHODS: S-TPI predictions were compared with observed outcomes in terms of normal/near-normal (modified Rankin Scale score, ≤1) and catastrophic outcome (modified Rankin Scale score, ≥5) at 3 months. Logistic regression was used to calibrate and expand the S-TPI. RESULTS: The S-TPI overestimated probability of catastrophic outcomes and overestimated the probability of a normal/near normal outcome above 0.4 and underestimated those below. Calibrating the S-TPI minimized discrepancies between predicted and observed outcomes, in the case of normal/near-normal outcomes, where including additional predictors (serum glucose and signs of current infarction on pretreatment brain scan) further reduced discrepancies between predicted and observed outcomes. CONCLUSIONS: The explanatory power of the S-TPI in thrombolytic-treated patients can be improved to reflect outcomes seen in routine practice.
BACKGROUND AND PURPOSE: This study aimed to test the explanatory qualities of the Stroke-Thrombolytic Predictive Instrument (S-TPI) when applied to patients treated in routine practice. METHODS: S-TPI predictions were compared with observed outcomes in terms of normal/near-normal (modified Rankin Scale score, ≤1) and catastrophic outcome (modified Rankin Scale score, ≥5) at 3 months. Logistic regression was used to calibrate and expand the S-TPI. RESULTS: The S-TPI overestimated probability of catastrophic outcomes and overestimated the probability of a normal/near normal outcome above 0.4 and underestimated those below. Calibrating the S-TPI minimized discrepancies between predicted and observed outcomes, in the case of normal/near-normal outcomes, where including additional predictors (serum glucose and signs of current infarction on pretreatment brain scan) further reduced discrepancies between predicted and observed outcomes. CONCLUSIONS: The explanatory power of the S-TPI in thrombolytic-treated patients can be improved to reflect outcomes seen in routine practice.
Authors: Shadi Yaghi; Amelia K Boehme; Jamil Dibu; Christopher R Leon Guerrero; Syed Ali; Sheryl Martin-Schild; Kara A Sands; Ali Reza Noorian; Christina A Blum; Shuchi Chaudhary; Lee H Schwamm; David S Liebeskind; Randolph S Marshall; Joshua Z Willey Journal: JAMA Neurol Date: 2015-12 Impact factor: 18.302
Authors: Darren Flynn; Daniel J Nesbitt; Gary A Ford; Peter McMeekin; Helen Rodgers; Christopher Price; Christian Kray; Richard G Thomson Journal: BMC Med Inform Decis Mak Date: 2015-02-07 Impact factor: 2.796
Authors: Peter McMeekin; Darren Flynn; Gary A Ford; Helen Rodgers; Jo Gray; Richard G Thomson Journal: BMC Med Inform Decis Mak Date: 2015-11-11 Impact factor: 2.796